Bibliografia
1. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol. 2008; 121(6):1344-50.
2. Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005; 14:254-258.
3. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 1994; 91:6688-92.
4. Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J Bacteriol. 2010; 192:5002-5017.
5. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science. 2005; 308(5728):1635-8.
6. Williams AM, Probert CS, Stepankova R et al. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology. 2006; 119(4):470-8.
7. Schezenmeir J. and de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am. J. Clin. Nutr. 2001; 73(suppl 2):361S-364S.
8. Ng SC, Hart AL, Kamm MA et al. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009; 15(2):300-10.
9. Mack DR, Michail S, Wei S et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol. 1999; 276(4 Pt 1):G941-50.
10. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004; 127(1):224-38.
11. Tao Y, Drabik KA, Waypa TS et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol. 2006; 290(4):C1018-30. Erratum in: Am J Physiol Cell Physiol. 2006; 291(1):C194.
12. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006; 60(2):221-4.
13. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002; 277:50959-50965.
14. Madara J. Building an intestine-architectural contributions of commensal bacteria. N Engl J Med. 2004; 351(16):1685-6.
15. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-95.
16. Jijon H, Backer J, Diaz H et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology. 2004; 126:1358-1373.
17. Madsen KL, Doyle JS, Jewell LD et al. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 1999; 116:107-1114.
18. Madsen KL, Doyle JS, Tavernini MM et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000; 118:1094-1105.
19. Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520- 528.
20. Smits HH, Engering A, van der KD et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005; 115:1260-1267.
21. Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factorb. Immunology 2008; 123:197-208.
22. Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immunol. 2002; 110:617-623.
23. Lyons A, O’Mahony D, O’Brien F et al. Bacterial strain-specific induction of Foxp3 T regulatory cells is protective in murine allergy models. Clin Exp Allergy. 2010; 40:811-819.
24. Ouwehand AC, Nermes M, Collado MC et al. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol. 2009; 15:3261-3268.
25. Wassenberg J, Nutten S, Audran R et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy. 2011; 41:565-573.
26. Wang MF, Lin HC, Wang YY et al. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol. 2004; 15:152-158.
27. Schiffer C, Lalanne AI, Cassard L et al. A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J Immunol. 2011; 187(5):2646-55.
28. Feleszko W, Jaworska J, Rha RD et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 2007; 37:498-505.
29. Chapat, L., Chemin, K., Dubois, B et al. Lactobacillus casei reduces CD8þ T cell-mediated skin inflammation. Eur. J. Immunol. 2004; 34:2520-2528.
30. Shida K, Takahashi R, Iwadate E et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy. 2002; 32(4):563-70.
31. Dev S, Mizuguchi H, Das AK et al Suppression of histamine signaling by probiotic Lac-B: a possible mechanism of its antiallergic effect. J Pharmacol Sci. 2008; 107(2):159-66.
32. Ohkouchi K, Kawamoto S, Tatsugawa K et al. Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen. J Biosci Bioeng. 2012; 113:536-41.
33. Wickens K, Black PN, Stanley TV et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a doubleblind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008; 122(4):788-94.
|